{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:10:03Z","timestamp":1790676603022,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ajog.2021.03.039","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T16:33:29Z","timestamp":1617294809000},"page":"432.e1-432.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with hemolysis, elevated liver enzymes, and low platelet count syndrome?"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-8210","authenticated-orcid":false,"given":"Mathilde","family":"P\u00e9court","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Yelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ghesquiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lodie","family":"Drumez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9meline","family":"Cailliau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Debarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Garabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.03.039_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/aogs.13322","article-title":"HELLP syndrome, risk factors in first and second pregnancy: a population-based cohort study","volume":"97","author":"Malmstr\u00f6m","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.03.039_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.03.039_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00296-007-0386-6","article-title":"Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome","volume":"28","author":"Tsirigotis","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ajog.2021.03.039_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2021.03.039_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2021.03.039_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0248-8663(02)00013-9","article-title":"[Antiphospholipid antibodies in HELLP syndrome: clinical and biological study in 68 women]","volume":"24","author":"Queyrel","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ajog.2021.03.039_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi Thuong","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajog.2021.03.039_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases","volume":"14","author":"Alijotas-Reig","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajog.2021.03.039_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.semarthrit.2011.05.007","article-title":"HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies","volume":"41","author":"Appenzeller","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ajog.2021.03.039_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1191\/0961203303lu378xx","article-title":"Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy","volume":"12","author":"Roberts","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2021.03.039_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2015.09.021","article-title":"Associations between phenotypes of preeclampsia and thrombophilia","volume":"194","author":"Berks","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.03.039_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","article-title":"The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.039_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/14767058.2013.773308","article-title":"HELLP syndrome and composite major maternal morbidity: importance of Mississippi classification system","volume":"26","author":"Martin","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.03.039_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/jth.14560","article-title":"Clinical and laboratory practice for lupus anticoagulant testing: an International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey","volume":"17","author":"Cohen","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2021.03.039_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.039_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2005.07.011","article-title":"Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies","volume":"125","author":"Deruelle","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.03.039_bib17","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2021.03.039_bib18","doi-asserted-by":"crossref","first-page":"e000131","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ajog.2021.03.039_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jri.2008.11.001","article-title":"Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes","volume":"79","author":"Yamada","year":"2009","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2021.03.039_bib20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:34:41Z","timestamp":1757590481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0002937821002192"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.03.039","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with hemolysis, elevated liver enzymes, and low platelet count syndrome?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}